Honorary Consultant Neurologist, Plymouth Hospitals NHS Trust
Prof. Camille Carroll is Professor of Clinical Neuroscience at the University of Plymouth, leading the Parkinson’s service in Plymouth to 3 national awards. Her research is focused on disease modification and the use of digital health technologies for monitoring and personalized care in Parkinson’s. Prof. Carroll was the chief investigator of a multi-centre clinical trial of simvastatin as a disease modifying agent in Parkinson’s disease (PD STAT). She co-leads the Edmond J Safra ACT-PD initiative, developing a multi-arm, multi-stage trial platform for disease modifying interventions in Parkinson’s. She is the NIHR CRN National Specialty Lead for Neurodegenerative Diseases, overseeing a balanced clinical trial portfolio in neurodegenerative disorders. She leads the CRN Remote Methods of Trial Delivery working group and was a steering group member for NIHR Include. She is Clinical co-Director of the Parkinson’s Excellence Network in the UK and has been internationally recognized for her patient-centred approach, broadening the opportunity for Parkinson’s research and improving support for patient care and self-management.